131 results
Page 4 of 7
8-K
EX-10.1
n1rqgse9u 8u
31 Aug 20
Hoth Therapeutics Appoints Dr. Stefanie Johns, Ph.D., as Chief Scientific Officer
4:25pm
8-K
z49c7grq21xahd6rd
5 Aug 20
Hoth Therapeutics’ Executes Licensing Agreement of VNLG-152 for Treatment of Dermatological Diseases
4:13pm
8-K
EX-10.1
3rw2o7
5 Aug 20
Hoth Therapeutics’ Executes Licensing Agreement of VNLG-152 for Treatment of Dermatological Diseases
4:13pm
8-K
EX-10.1
0nq4p 9ug9bnqn
2 Jul 20
Hoth Therapeutics Announces Sponsored Research Agreement with VCU for Potential COVID-19 Treatment
8:00am
424B5
x0w0d0yhf8v3yrvwfxs
22 May 20
Prospectus supplement for primary offering
4:35pm
8-K
EX-1.1
lag4g
22 May 20
Hoth Announces Pricing of Public Offering of Shares of Common Stock
4:05pm
424B5
4iz84 pewr
21 May 20
Prospectus supplement for primary offering
4:40pm
8-K
n0sgc7qmv0v6x
21 May 20
Hoth Announces Proposed Public Offering of Common Stock
4:02pm
8-K
EX-99.2
svwela n3wx9cw7gub
21 May 20
Hoth Announces Proposed Public Offering of Common Stock
4:02pm
DEF 14A
8w18yym5bn1xf pxa8
19 May 20
Definitive proxy
4:17pm
424B3
k4pht zcwmlncsou
7 May 20
Prospectus supplement
6:02am
424B5
24fa3rc
25 Mar 20
Prospectus supplement for primary offering
4:31pm
8-K
EX-1.1
7q4onr5btd090l9hz
25 Mar 20
Hoth Announces Proposed Public Offering of Common Stock
4:15pm
424B5
vv2xrz3slysci62ah
23 Mar 20
Prospectus supplement for primary offering
5:13pm
8-K
EX-10.1
h5c9q0ayhxxalgnig3a
23 Mar 20
Entry into a Material Definitive Agreement
5:10pm